Funding Homeless Programs

The opinion piece in the Nov. 10, 1997, issue of The Scientist [W. Breakey, "Homelessness Should Be Treated As A Major Health Issue," page 8] suggests dealing with the homeless problem by providing more health care and "adequate" housing. This sounds like a heartwarming solution, but Breakey doesn't explain where the money for these programs will come from. Considering the fact that the federal government is one of the least efficient charities, handing out only 28 cents to welfare recipients f

Written byBoyd
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The opinion piece in the Nov. 10, 1997, issue of The Scientist [W. Breakey, "Homelessness Should Be Treated As A Major Health Issue," page 8] suggests dealing with the homeless problem by providing more health care and "adequate" housing.

This sounds like a heartwarming solution, but Breakey doesn't explain where the money for these programs will come from. Considering the fact that the federal government is one of the least efficient charities, handing out only 28 cents to welfare recipients for each dollar the taxpayers put into the system, how is he proposing to fund his program?

A recent federal study shows that 25 percent to 30 percent of the homeless in America are mentally disabled and 40 percent are substance abusers (cited in D.B. Wood, "Innovations for Helping the Homeless," Christian Science Monitor, Nov. 28, 1997, page 1). Under Breakey's plan, will the homeless be constrained to stay in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies